Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
SteadyMed Ltd. (STDY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/30/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
08/14/2018 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results"
08/01/2018 8-K Submission of Matters to a Vote of Security Holders
07/20/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd."
06/29/2018 8-K Other Events
04/30/2018 8-K Quarterly results
03/30/2018 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results Company on Track for Trevyent™ NDA Resubmission"
01/04/2018 8-K Submission of Matters to a Vote of Security Holders
11/13/2017 8-K Quarterly results
Docs: "SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
09/05/2017 8-K Quarterly results
08/11/2017 8-K Quarterly results
Docs: "SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update"
05/12/2017 8-K Form 8-K - Current report
04/21/2017 8-K Form 8-K - Current report
03/29/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
10/18/2016 8-K Form 8-K - Current report
10/11/2016 8-K Form 8-K - Current report
08/15/2016 8-K Quarterly results
Docs: "STEADYMED PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS SAN RAMON, Calif., August 15, 2016 — SteadyMed Ltd. , a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today provided a corporate update and announced its financial results for the second quarter ended June 30, 2016. First Half 2016 Corporate Update:"
07/29/2016 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Subscription Agreement, by and among SteadyMed Ltd. and Participants defined therein",
"###"
05/11/2016 8-K Quarterly results
Docs: "SteadyMed Provides Corporate Update and Reports First Quarter 2016 Financial Results"
03/29/2016 8-K Form 8-K - Current report
03/08/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "STEADYMED REPORTS RECENT DEVELOPMENTS AND THIRD QUARTER 2015 FINANCIAL RESULTS"
08/13/2015 8-K Quarterly results
Docs: "STEADYMED PROVIDES INSIGHTS ON RECENT CORPORATE DEVELOPMENTS AND REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS"
08/11/2015 8-K Submission of Matters to a Vote of Security Holders
07/02/2015 8-K Entry into a Material Definitive Agreement
06/16/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/04/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "First Lease Addendum dated May 29, 2015, by and between SteadyMed Therapeutics, Inc. and Sunset Land Company, LLC",
"Third Lease Addendum, by and between SteadyMed Therapeutics, Inc. and Annabel Investment Company"
05/14/2015 8-K Quarterly results
Docs: "STEADYMED REPORTS RECENT DEVELOPMENTS, FINANCIAL HIGHLIGHTS AND FIRST QUARTER 2015 FINANCIAL RESULTS"
05/06/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Bishop Ranch Building Lease, by and between SteadyMed Therapeutics, Inc. and Sunset Land Company, LLC"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy